Categories: HealthcareNews

Dr. Marlene Grenon, MD, MBA, Joins CareSimple Board of Directors

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

Renowned Medical Innovator and Business Strategist, Dr. Marlene Grenon, Joins CareSimple’s Board, Bringing a Wealth of Expertise in Digital Health and AI to Revolutionize Remote Patient Monitoring and Enhance Healthcare Accessibility and Efficiency

PALM BEACH GARDENS, FL / ACCESSWIRE / December 5, 2023 / CareSimple, the premier enterprise-level remote patient monitoring (RPM) solution, has announced the appointment of Dr. Marlene Grenon, MD, MBA, to its Board of Directors. Dr. Grenon brings a blend of medical expertise, business acumen, and technical proficiency that is poised to propel CareSimple’s mission to new heights.

CareSimple
© 2023 CareSimple® Inc.

Dr. Grenon says, “I am both honored and thrilled to join the board of CareSimple. As someone who has spent decades at the intersection of medicine, technology, and business, I find CareSimple’s approach to RPM a perfect alignment with my own beliefs in patient-centered care. The company’s vision of making healthcare both proactive and accessible resonates strongly with me. I look forward to contributing my experience and expertise to help CareSimple navigate the complex healthcare landscape, foster innovation, and most importantly, improve patient outcomes.”

Exceptional Educational Credentials

Elite Training: Dr. Grenon holds an Executive MBA from Brown University and IE Business School, an MSc in Clinical Investigations from Harvard Medical School, an MD from McGill University, and a Diploma in Space Sciences from the International Space University.

Academic Excellence: She is the author of four books and has contributed to 75+ peer-reviewed scientific publications. Her academic contributions earned her multiple awards, including from UCSF and NASA.

Multi-Faceted Healthcare Expertise

Diverse Roles: With over 20 years of healthcare experience spanning roles as a physician, cardiovascular surgeon, Chief Medical Officer, and C-level executive, Dr. Grenon’s multi-dimensional perspective is a tremendous asset.

Network & Governance: Her affiliations with organizations like UCSF, NASA, and MIT provide CareSimple with a wealth of strategic opportunities and governance experience.

Innovation & Commercialization

Technology & AI: Dr. Grenon’s focus on digital health, AI, and commercialization aligns seamlessly with CareSimple’s tech-forward ethos.

Commercial Savvy: Having guided startups and developed commercialization strategies, her expertise will help CareSimple scale effectively and responsibly.

Awards & Recognitions

Prestigious Honors: Among her accolades are an “Achievement Award” from NASA, “Medical Student Teaching Awards” from UCSF, and being a Finalist in the Canadian Astronaut Recruitment Campaign.

From Michel Nadeau, CareSimple’s CEO and Chairman of the board:

“We couldn’t be more excited to have Dr. Grenon join our board. Her incredible background, multiple roles in healthcare, and commercial expertise make her a perfect fit for guiding CareSimple as we continue to innovate and scale. We’re particularly excited about her experience in both the Canadian and U.S. healthcare landscapes, which mirrors CareSimple’s dual focus.”

About CareSimple®

CareSimple is a leading provider of enterprise-level remote patient monitoring (RPM) solutions, designed to streamline operations and improve patient outcomes for payers and health systems, offering advanced, user-friendly technology to ensure efficient, high-quality care in the evolving landscape of healthcare. For more information about CareSimple, go to https://caresimple.com.

Contact Information

Martin Leclerc
Vice President Of Sales & Business Development
mleclerc@caresimple.com

SOURCE: CareSimple Inc.

View source version on accesswire.com:
https://www.accesswire.com/812930/dr-marlene-grenon-md-mba-joins-caresimple-board-of-directors

Staff

Recent Posts

Hemostemix Closes $469,366 Private Placement

Calgary, Alberta--(Newsfile Corp. - July 4, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE:…

36 minutes ago

Immuthera’s Scientific Advisory Board: World-Leading Expertise Driving Next-Generation Diabetes and Immunotherapy Solutions

Immuthera’s Scientific Advisory Board: World-Leading Expertise Driving Next-Generation Diabetes and Immunotherapy Solutions Distinguished experts Dr.…

36 minutes ago

Virbac : Declaration of the number of shares and voting rights 06/2025

DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of…

36 minutes ago

AB Science: Masitinib receives FDA and EMA authorization for confirmatory phase 3 trial in metastatic castrate-resistant prostate cancer

PRESS RELEASE MASITINIB RECEIVES FDA AND EMA AUTHORIZATION FOR CONFIRMATORY PHASE 3 TRIAL IN METASTATIC…

36 minutes ago

Strüngmann Award Honors Araris Biotech Founding Team as 2025 Winner

The expert jury selected Dragan Grabulovski, Ph.D., Philipp Spycher, Ph.D., and Isabella Attinger-Toller, Ph.D. of…

36 minutes ago